Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells
The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)-proteasome...
Saved in:
Published in | International journal of oncology Vol. 46; no. 2; pp. 474 - 486 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
D.A. Spandidos
01.02.2015
Spandidos Publications Spandidos Publications UK Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)-proteasome and autophagy-lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2-reagent combination. CAM/BZ treatment induced vimentin positive-aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild-type murine embryonic fibroblast (MEF) cell line; however, a CHOP-deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ-induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress-mediated apoptosis in MM cells. |
---|---|
AbstractList | The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)‑proteasome and autophagy‑lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2‑reagent combination. CAM/BZ treatment induced vimentin positive‑aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild‑type murine embryonic fibroblast (MEF) cell line; however, a CHOP‑deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ‑induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress‑mediated apoptosis in MM cells. The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)-proteasome and autophagy-lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2-reagent combination. CAM/BZ treatment induced vimentin positive-aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild-type murine embryonic fibroblast (MEF) cell line; however, a CHOP-deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ-induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress-mediated apoptosis in MM cells. Key words: multiple myeloma, aggresome, proteasome, autophagy, ER stress |
Audience | Academic |
Author | CHE, XIAO-FANG YAMASAKI, KAHO KOKUBA, HIROKO HIROTA, AYAKO MORIYA, SHOTA KOMATSU, SEIICHIRO KAWAI, YUSUKE HIRAMOTO, MASAKI MIYAZAWA, KEISUKE INAZU, MASATO GOTOH, AKIHIKO |
AuthorAffiliation | 4 Institute of Medical Science, Tokyo Medical University, Tokyo, Japan 1 Department of Biochemistry, Tokyo Medical University, Tokyo, Japan 2 Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan 3 Laboratory of Electron Microscopy, Tokyo Medical University, Tokyo, Japan 5 Department of Hematology, Juntendo University, Tokyo, Japan |
AuthorAffiliation_xml | – name: 2 Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan – name: 1 Department of Biochemistry, Tokyo Medical University, Tokyo, Japan – name: 4 Institute of Medical Science, Tokyo Medical University, Tokyo, Japan – name: 5 Department of Hematology, Juntendo University, Tokyo, Japan – name: 3 Laboratory of Electron Microscopy, Tokyo Medical University, Tokyo, Japan |
Author_xml | – sequence: 1 givenname: SHOTA surname: MORIYA fullname: MORIYA, SHOTA organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan – sequence: 2 givenname: SEIICHIRO surname: KOMATSU fullname: KOMATSU, SEIICHIRO organization: Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan – sequence: 3 givenname: KAHO surname: YAMASAKI fullname: YAMASAKI, KAHO organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan – sequence: 4 givenname: YUSUKE surname: KAWAI fullname: KAWAI, YUSUKE organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan – sequence: 5 givenname: HIROKO surname: KOKUBA fullname: KOKUBA, HIROKO organization: Laboratory of Electron Microscopy, Tokyo Medical University, Tokyo, Japan – sequence: 6 givenname: AYAKO surname: HIROTA fullname: HIROTA, AYAKO organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan – sequence: 7 givenname: XIAO-FANG surname: CHE fullname: CHE, XIAO-FANG organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan – sequence: 8 givenname: MASATO surname: INAZU fullname: INAZU, MASATO organization: Institute of Medical Science, Tokyo Medical University, Tokyo, Japan – sequence: 9 givenname: AKIHIKO surname: GOTOH fullname: GOTOH, AKIHIKO organization: Department of Hematology, Juntendo University, Tokyo, Japan – sequence: 10 givenname: MASAKI surname: HIRAMOTO fullname: HIRAMOTO, MASAKI organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan – sequence: 11 givenname: KEISUKE surname: MIYAZAWA fullname: MIYAZAWA, KEISUKE organization: Department of Biochemistry, Tokyo Medical University, Tokyo, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25422130$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UluL1DAYLbLiXvTRVwkI-rIdc-vtZWFZ1gssCLI-hzT92mZsm5qkyvwS_67fzOyuO6IkkJDvnJOTfOc0OZrcBEnyktGVKCv-zq7dilMmV7woxJPkhBUVS7nk4gj3lFVpLkV1nJyGsKaUZxllz5JjnknOmaAnya9b7TuIdupI7IHYKULndYSGTBB_Ov8tENcS3XUeghuBtM6POlo3nZPZuwh6e3pO9NQQvUQ397rbkBkLU7QoE8j1FxIikkM6QmN3ygaGgTSgY4_3kXEZop0HIOMGBjfqXTk8T562egjw4m49S76-v769-pjefP7w6eryJjU5YzEtueEG8rLVnLfCcFoJCVVhipKZGjIKRY2zKkqZUdPUdVYXmja50RWAlGUuzpKLve681GjQoG-vBzV7O2q_UU5bdViZbK8690NJ_G8uMxR4fSfg3fcFQlRrt_gJPStWCV5yWVH5B9XpAZSdWodiZrTBqEtJmSgZukHU6h8oHA2M1mDfW4vnB4Q3jwg96CH2wQ3LtkHhEPjq8TMf3ncfBASIPcB4F4KHVhkbd41GC3ZQjKpt3BTGTW3jprZxQ1b6F-te-H_4t3t8mDExtnHhgYDAVOYp5SmVhRS_Ac2O5jY |
CitedBy_id | crossref_primary_10_1002_med_21972 crossref_primary_10_1038_s41420_022_01293_x crossref_primary_10_1186_s13046_024_03071_2 crossref_primary_10_1186_s13256_017_1550_6 crossref_primary_10_3892_ol_2023_14146 crossref_primary_10_1074_jbc_M116_717793 crossref_primary_10_3892_ijo_2015_3237 crossref_primary_10_3389_fimmu_2021_795053 crossref_primary_10_3390_cancers16132381 crossref_primary_10_3892_ol_2021_12941 crossref_primary_10_1016_j_celrep_2020_107897 crossref_primary_10_1038_s41598_020_73298_4 crossref_primary_10_2174_1389450121666200525004714 crossref_primary_10_1111_febs_14811 crossref_primary_10_3892_ijo_2016_3673 crossref_primary_10_1038_s41598_019_49027_x crossref_primary_10_18632_oncotarget_17862 crossref_primary_10_3390_cancers14205072 crossref_primary_10_3892_or_2017_5932 crossref_primary_10_1016_j_bbrc_2018_05_001 crossref_primary_10_1039_C5SC01351H crossref_primary_10_1016_j_jbc_2024_107398 crossref_primary_10_1016_j_jgg_2024_07_017 crossref_primary_10_3390_ijms24076019 crossref_primary_10_1038_s41416_023_02210_4 crossref_primary_10_1016_j_devcel_2020_03_011 crossref_primary_10_1016_j_ebiom_2023_104961 crossref_primary_10_1186_s12989_021_00430_1 crossref_primary_10_1016_j_eurpolymj_2024_113267 crossref_primary_10_1016_j_ejphar_2016_08_026 crossref_primary_10_20517_cdr_2023_108 crossref_primary_10_1016_j_canlet_2024_216978 crossref_primary_10_1248_bpb_b18_00785 crossref_primary_10_1016_j_canlet_2019_02_003 crossref_primary_10_1158_1541_7786_MCR_15_0135 crossref_primary_10_1080_10428194_2017_1376741 crossref_primary_10_1111_cas_14992 crossref_primary_10_1016_j_bbrc_2018_09_177 crossref_primary_10_1016_j_leukres_2016_07_006 crossref_primary_10_1016_j_bbrc_2015_03_162 crossref_primary_10_1007_s11060_020_03694_3 |
Cites_doi | 10.3892/ijo.2013.1870 10.1056/NEJMoa030288 10.1083/jcb.146.6.1239 10.1038/emboj.2009.405 10.1101/sqb.2011.76.011023 10.3892/ijo.2011.1317 10.1074/jbc.M111.273730 10.1038/emboj.2013.171 10.1007/s00401-013-1158-x 10.1586/14737175.6.9.1337 10.1053/j.seminoncol.2013.07.007 10.1038/nature06639 10.1038/ncb0311-184 10.1016/j.ymgme.2008.03.012 10.1038/nrd3976 10.1073/pnas.0430973100 10.3109/0284186X.2012.689113 10.1182/blood-2012-05-425934 10.1016/j.bbrc.2013.06.032 10.1056/NEJMoa0801479 10.1016/j.molcel.2009.04.026 10.1083/jcb.143.7.1883 10.1172/JCI46095 10.1155/2010/930509 10.1371/journal.pone.0040440 10.1038/ncomms3111 10.1182/blood-2013-07-517276 10.2146/ajhp090247 10.1038/417455a 10.1247/csf.23.33 10.1016/S1470-2045(13)70398-X 10.1016/S0092-8674(03)00939-5 10.1016/j.febslet.2009.12.047 10.1371/journal.pone.0076016 10.1200/JCO.2006.10.2434 10.1182/blood-2007-12-130823 10.1128/MCB.00103-14 |
ContentType | Journal Article |
Copyright | Copyright © 2015, Spandidos Publications COPYRIGHT 2015 Spandidos Publications Copyright Spandidos Publications UK Ltd. 2015 Copyright © 2015, Spandidos Publications 2015 |
Copyright_xml | – notice: Copyright © 2015, Spandidos Publications – notice: COPYRIGHT 2015 Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2015 – notice: Copyright © 2015, Spandidos Publications 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 5PM |
DOI | 10.3892/ijo.2014.2773 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-2423 |
EndPage | 486 |
ExternalDocumentID | PMC4277245 A401381448 25422130 10_3892_ijo_2014_2773 ijo-46-02-0474 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | - 0R 2WC 3V. 53G 5GY 7RV 7X7 88E 8FI 8FJ AAPBV AASXA ABFLS ABPMR ABUWG ACGFS ADACO ADBBV ADCBC AENEX AFKRA AGCAB AHMBA ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BBAFP BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CS3 DIK DU5 E3Z EBD EBS EJD F5P FYUFA H13 HUR HZ IAO IHR IHW INH INR ITC L7B M1P O9- OGEVE OVD P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO RIG SV3 UDS ZXP --- 0R~ AAFWJ AAYXX ABJNI ACGFO AEGXH AFOSN AIAGR ALIPV CCPQU CITATION EMOBN HMCUK HZ~ IPNFZ NAPCQ ODZKP OK1 PHGZM PHGZT TEORI TR2 UKHRP CGR CUY CVF ECM EIF NPM PMFND 7XB 8FK K9. PJZUB PKEHL PPXIY 5PM |
ID | FETCH-LOGICAL-c611t-82c2ce68fa22f3c20934e97c781cbe50e7be7b978450cdbb5b7a0d6ca9ee44863 |
IEDL.DBID | 7X7 |
ISSN | 1019-6439 |
IngestDate | Thu Aug 21 18:34:25 EDT 2025 Fri Jul 25 05:48:16 EDT 2025 Tue Jun 17 21:32:03 EDT 2025 Tue Jun 10 20:26:57 EDT 2025 Thu May 22 21:24:46 EDT 2025 Thu Jan 02 22:16:53 EST 2025 Tue Jul 01 03:20:41 EDT 2025 Thu Apr 24 22:58:05 EDT 2025 Tue Jan 05 23:28:36 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c611t-82c2ce68fa22f3c20934e97c781cbe50e7be7b978450cdbb5b7a0d6ca9ee44863 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC4277245 |
PMID | 25422130 |
PQID | 1932824904 |
PQPubID | 2044957 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4277245 proquest_journals_1932824904 gale_infotracmisc_A401381448 gale_infotracacademiconefile_A401381448 gale_healthsolutions_A401381448 pubmed_primary_25422130 crossref_citationtrail_10_3892_ijo_2014_2773 crossref_primary_10_3892_ijo_2014_2773 spandidos_primary_ijo-46-02-0474 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-02-01 |
PublicationDateYYYYMMDD | 2015-02-01 |
PublicationDate_xml | – month: 02 year: 2015 text: 2015-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece – name: Athens |
PublicationTitle | International journal of oncology |
PublicationTitleAlternate | Int J Oncol |
PublicationYear | 2015 |
Publisher | D.A. Spandidos Spandidos Publications Spandidos Publications UK Ltd |
Publisher_xml | – name: D.A. Spandidos – name: Spandidos Publications – name: Spandidos Publications UK Ltd |
References | Moriya, Che, Komatsu, Abe, Kawaguchi, Gotoh, Inazu, Tomoda, Miyazawa (b16-ijo-46-02-0474) 2013; 42 Haggarty, Koeller, Wong, Grozinger, Schreiber (b28-ijo-46-02-0474) 2003; 100 Yamamoto, Tagawa, Yoshimori, Moriyama, Masaki, Tashiro (b37-ijo-46-02-0474) 1998; 23 Richardson, Xie, Jagannath (b3-ijo-46-02-0474) 2014; 123 Komatsu, Moriya, Che, Yokoyama, Kohno, Miyazawa (b24-ijo-46-02-0474) 2013; 437 Lee, Koga, Kawaguchi (b21-ijo-46-02-0474) 2010; 29 Tabas, Ron (b9-ijo-46-02-0474) 2011; 13 Simms-Waldrip, Rodriguez-Gonzalez, Lin, Ikeda, Fu, Sakamoto (b18-ijo-46-02-0474) 2008; 94 Zaarur, Meriin, Bejarano, Xu, Gabai, Cuervo, Sherman (b35-ijo-46-02-0474) 2014; 34 Mizushima, Levine, Cuervo, Klionsky (b11-ijo-46-02-0474) 2008; 451 Garcia-Mata, Bebök, Sorscher, Sztul (b29-ijo-46-02-0474) 1999; 146 Johnston, Ward, Kopito (b30-ijo-46-02-0474) 1998; 143 Nakamura, Kikukawa, Takeya, Mitsuya, Hata (b36-ijo-46-02-0474) 2010; 37 Renna, Schaffner, Brown (b38-ijo-46-02-0474) 2011; 121 Yan, Seibenhener, Calderilla-Barbosa, Diaz-Meco, Moscat, Jiang, Wooten, Wooten (b23-ijo-46-02-0474) 2013; 8 Hetz, Chevet, Harding (b8-ijo-46-02-0474) 2013; 12 Kirkin, McEwan, Novak, Dikic (b13-ijo-46-02-0474) 2009; 34 San Miguel, Schlag, Khuageva (b2-ijo-46-02-0474) 2008; 359 Richardson, Barlogie, Berenson (b1-ijo-46-02-0474) 2003; 348 Mizushima (b12-ijo-46-02-0474) 2011; 76 Komatsu, Miyazawa, Moriya, Takase, Naito, Inazu, Kohno, Itoh, Tomoda (b17-ijo-46-02-0474) 2012; 40 Siegel, Martin, Wang (b4-ijo-46-02-0474) 2012; 120 Verfaillie, Salazar, Velasco, Agostinis (b10-ijo-46-02-0474) 2010; 2010 Kawaguchi, Miyazawa, Moriya, Ohtomo, Che, Naito, Itoh, Tomoda (b15-ijo-46-02-0474) 2011; 38 Kavanaugh, White, Kolesar (b26-ijo-46-02-0474) 2010; 67 Hubbert, Guardiola, Shao, Kawaguchi, Ito, Nixon, Yoshida, Wang, Yao (b27-ijo-46-02-0474) 2002; 417 Olsen, Kim, Kuzel (b25-ijo-46-02-0474) 2007; 25 Kawaguchi, Kovacs, McLaurin, Vance, Ito, Yao (b19-ijo-46-02-0474) 2003; 115 Orlowski (b6-ijo-46-02-0474) 2013; 40 Fusco, Micale, Egorov (b22-ijo-46-02-0474) 2012; 7 Maejima, Takahashi, Omori (b39-ijo-46-02-0474) 2013; 32 Martinon (b7-ijo-46-02-0474) 2012; 51 Hung, Chen, Yang, Yang (b31-ijo-46-02-0474) 2013; 4 Dimopoulos, Siegel, Lonial (b5-ijo-46-02-0474) 2013; 14 Ouyang, Ali, Ravichandran, Dong, Qiu, MacKenzie, Dhe-Paganon, Arrowsmith, Zhai (b20-ijo-46-02-0474) 2012; 287 Richter-Landsberg, Leyk (b32-ijo-46-02-0474) 2013; 126 Korolchuk, Menzies, Rubinsztein (b14-ijo-46-02-0474) 2010; 584 Hol, Fischer, Ovaa, Scheper (b33-ijo-46-02-0474) 2006; 6 Nawrocki, Carew, Maclean, Courage, Huang, Houghton, Cleveland, Giles, McConkey (b34-ijo-46-02-0474) 2008; 112 Richardson (key20180107183959_b1-ijo-46-02-0474) 2003; 348 Siegel (key20180107183959_b4-ijo-46-02-0474) 2012; 120 Hung (key20180107183959_b31-ijo-46-02-0474) 2013; 4 Kavanaugh (key20180107183959_b26-ijo-46-02-0474) 2010; 67 Zaarur (key20180107183959_b35-ijo-46-02-0474) 2014; 34 Mizushima (key20180107183959_b11-ijo-46-02-0474) 2008; 451 Olsen (key20180107183959_b25-ijo-46-02-0474) 2007; 25 Fusco (key20180107183959_b22-ijo-46-02-0474) 2012; 7 Verfaillie (key20180107183959_b10-ijo-46-02-0474) 2010; 2010 Kirkin (key20180107183959_b13-ijo-46-02-0474) 2009; 34 Komatsu (key20180107183959_b17-ijo-46-02-0474) 2012; 40 Hetz (key20180107183959_b8-ijo-46-02-0474) 2013; 12 Nawrocki (key20180107183959_b34-ijo-46-02-0474) 2008; 112 Komatsu (key20180107183959_b24-ijo-46-02-0474) 2013; 437 Kawaguchi (key20180107183959_b19-ijo-46-02-0474) 2003; 115 Haggarty (key20180107183959_b28-ijo-46-02-0474) 2003; 100 Martinon (key20180107183959_b7-ijo-46-02-0474) 2012; 51 Tabas (key20180107183959_b9-ijo-46-02-0474) 2011; 13 Maejima (key20180107183959_b39-ijo-46-02-0474) 2013; 32 Renna (key20180107183959_b38-ijo-46-02-0474) 2011; 121 Richardson (key20180107183959_b3-ijo-46-02-0474) 2014; 123 Ouyang (key20180107183959_b20-ijo-46-02-0474) 2012; 287 Hol (key20180107183959_b33-ijo-46-02-0474) 2006; 6 Korolchuk (key20180107183959_b14-ijo-46-02-0474) 2010; 584 Dimopoulos (key20180107183959_b5-ijo-46-02-0474) 2013; 14 Nakamura (key20180107183959_b36-ijo-46-02-0474) 2010; 37 Yan (key20180107183959_b23-ijo-46-02-0474) 2013; 8 Hubbert (key20180107183959_b27-ijo-46-02-0474) 2002; 417 Lee (key20180107183959_b21-ijo-46-02-0474) 2010; 29 San Miguel (key20180107183959_b2-ijo-46-02-0474) 2008; 359 Moriya (key20180107183959_b16-ijo-46-02-0474) 2013; 42 Mizushima (key20180107183959_b12-ijo-46-02-0474) 2011; 76 Simms-Waldrip (key20180107183959_b18-ijo-46-02-0474) 2008; 94 Richter-Landsberg (key20180107183959_b32-ijo-46-02-0474) 2013; 126 Garcia-Mata (key20180107183959_b29-ijo-46-02-0474) 1999; 146 Yamamoto (key20180107183959_b37-ijo-46-02-0474) 1998; 23 Johnston (key20180107183959_b30-ijo-46-02-0474) 1998; 143 Orlowski (key20180107183959_b6-ijo-46-02-0474) 2013; 40 Kawaguchi (key20180107183959_b15-ijo-46-02-0474) 2011; 38 22686473 - Acta Oncol. 2012 Sep;51(7):822-30 20145727 - Int J Cell Biol. 2010;2010:930509 21174067 - Int J Oncol. 2011 Mar;38(3):643-54 21804191 - J Clin Invest. 2011 Sep;121(9):3554-63 10491388 - J Cell Biol. 1999 Sep 20;146(6):1239-54 24135408 - Semin Oncol. 2013 Oct;40(5):634-51 23921551 - EMBO J. 2013 Aug 28;32(17):2336-47 23912309 - Acta Neuropathol. 2013 Dec;126(6):793-807 9864362 - J Cell Biol. 1998 Dec 28;143(7):1883-98 20075865 - EMBO J. 2010 Mar 3;29(5):969-80 22200786 - Int J Oncol. 2012 Apr;40(4):1029-39 22792322 - PLoS One. 2012;7(7):e40440 12677000 - Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4389-94 14675537 - Cell. 2003 Dec 12;115(6):727-38 24429336 - Blood. 2014 Mar 6;123(10):1461-9 19450525 - Mol Cell. 2009 May 15;34(3):259-69 21364565 - Nat Cell Biol. 2011 Mar;13(3):184-90 18472289 - Mol Genet Metab. 2008 Jul;94(3):283-6 24469403 - Mol Cell Biol. 2014 Apr;34(7):1336-48 12024216 - Nature. 2002 May 23;417(6887):455-8 23792097 - Biochem Biophys Res Commun. 2013 Jul 19;437(1):41-7 22833546 - Blood. 2012 Oct 4;120(14):2817-25 23989796 - Nat Rev Drug Discov. 2013 Sep;12(9):703-19 23817530 - Nat Commun. 2013;4:2111 18305538 - Nature. 2008 Feb 28;451(7182):1069-75 24086678 - PLoS One. 2013;8(9):e76016 22069321 - J Biol Chem. 2012 Jan 20;287(4):2317-27 18641367 - Blood. 2008 Oct 1;112(7):2917-26 18753647 - N Engl J Med. 2008 Aug 28;359(9):906-17 9639028 - Cell Struct Funct. 1998 Feb;23(1):33-42 20040365 - FEBS Lett. 2010 Apr 2;584(7):1393-8 24055414 - Lancet Oncol. 2013 Oct;14(11):1129-40 23546223 - Int J Oncol. 2013 May;42(5):1541-50 12826635 - N Engl J Med. 2003 Jun 26;348(26):2609-17 20811702 - Int J Oncol. 2010 Oct;37(4):815-20 21813637 - Cold Spring Harb Symp Quant Biol. 2011;76:397-402 20479100 - Am J Health Syst Pharm. 2010 May 15;67(10):793-7 17009921 - Expert Rev Neurother. 2006 Sep;6(9):1337-47 17577020 - J Clin Oncol. 2007 Jul 20;25(21):3109-15 |
References_xml | – volume: 451 start-page: 1069 year: 2008 end-page: 1075 ident: b11-ijo-46-02-0474 article-title: Autophagy fights disease through cellular self-digestion publication-title: Nature – volume: 2010 start-page: 930509 year: 2010 ident: b10-ijo-46-02-0474 article-title: Linking ER stress to autophagy: potential implications for cancer therapy publication-title: Int J Cell Biol – volume: 146 start-page: 1239 year: 1999 end-page: 1254 ident: b29-ijo-46-02-0474 article-title: Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera publication-title: J Cell Biol – volume: 32 start-page: 2336 year: 2013 end-page: 2347 ident: b39-ijo-46-02-0474 article-title: Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury publication-title: EMBO J – volume: 51 start-page: 822 year: 2012 end-page: 830 ident: b7-ijo-46-02-0474 article-title: Targeting endoplasmic reticulum signaling pathways in cancer publication-title: Acta Oncol – volume: 120 start-page: 2817 year: 2012 end-page: 2825 ident: b4-ijo-46-02-0474 article-title: A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma publication-title: Blood – volume: 40 start-page: 1029 year: 2012 end-page: 1039 ident: b17-ijo-46-02-0474 article-title: Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells publication-title: Int J Oncol – volume: 112 start-page: 2917 year: 2008 end-page: 2926 ident: b34-ijo-46-02-0474 article-title: Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA publication-title: Blood – volume: 100 start-page: 4389 year: 2003 end-page: 4394 ident: b28-ijo-46-02-0474 article-title: Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation publication-title: Proc Natl Acad Sci USA – volume: 584 start-page: 1393 year: 2010 end-page: 1398 ident: b14-ijo-46-02-0474 article-title: Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems publication-title: FEBS Lett – volume: 23 start-page: 33 year: 1998 end-page: 42 ident: b37-ijo-46-02-0474 article-title: Bafilomycin A prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells publication-title: Cell Struct Funct – volume: 38 start-page: 643 year: 2011 end-page: 654 ident: b15-ijo-46-02-0474 article-title: Combined treatment with bortezomib plus bafilomycin A enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: Crosstalk among proteasome, autophagy-lysosome and ER stress publication-title: Int J Oncol – volume: 143 start-page: 1883 year: 1998 end-page: 1898 ident: b30-ijo-46-02-0474 article-title: Aggresomes: a cellular response to misfolded proteins publication-title: J Cell Biol – volume: 34 start-page: 1336 year: 2014 end-page: 1348 ident: b35-ijo-46-02-0474 article-title: Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport publication-title: Mol Cell Biol – volume: 6 start-page: 1337 year: 2006 end-page: 1347 ident: b33-ijo-46-02-0474 article-title: Ubiquitin proteasome system as a pharmacological target in neurodegeneration publication-title: Expert Rev Neurother – volume: 437 start-page: 41 year: 2013 end-page: 47 ident: b24-ijo-46-02-0474 article-title: Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells publication-title: Biochem Biophys Res Commun – volume: 42 start-page: 1541 year: 2013 end-page: 1550 ident: b16-ijo-46-02-0474 article-title: Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells publication-title: Int J Oncol – volume: 4 start-page: 2111 year: 2013 ident: b31-ijo-46-02-0474 article-title: Spatiotemporally controlled induction of autophagy-mediated lysosome turnover publication-title: Nat Commun – volume: 417 start-page: 455 year: 2002 end-page: 458 ident: b27-ijo-46-02-0474 article-title: HDAC6 is a microtubule-associated deacetylase publication-title: Nature – volume: 121 start-page: 3554 year: 2011 end-page: 3563 ident: b38-ijo-46-02-0474 article-title: Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection publication-title: J Clin Invest – volume: 14 start-page: 1129 year: 2013 end-page: 1140 ident: b5-ijo-46-02-0474 article-title: Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study publication-title: Lancet Oncol – volume: 67 start-page: 793 year: 2010 end-page: 797 ident: b26-ijo-46-02-0474 article-title: Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma publication-title: Am J Health Syst Pharm – volume: 8 start-page: e76016 year: 2013 ident: b23-ijo-46-02-0474 article-title: SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity publication-title: PLoS One – volume: 40 start-page: 634 year: 2013 end-page: 651 ident: b6-ijo-46-02-0474 article-title: Novel agents for multiple myeloma to overcome resistance in phase III clinical trials publication-title: Semin Oncol – volume: 76 start-page: 397 year: 2011 end-page: 402 ident: b12-ijo-46-02-0474 article-title: Autophagy in protein and organelle turnover publication-title: Cold Spring Harb Symp Quant Biol – volume: 348 start-page: 2609 year: 2003 end-page: 2617 ident: b1-ijo-46-02-0474 article-title: A phase 2 study of bortezomib in relapsed, refractory myeloma publication-title: N Engl J Med – volume: 34 start-page: 259 year: 2009 end-page: 269 ident: b13-ijo-46-02-0474 article-title: A role for ubiquitin in selective autophagy publication-title: Mol Cell – volume: 287 start-page: 2317 year: 2012 end-page: 2327 ident: b20-ijo-46-02-0474 article-title: Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini publication-title: J Biol Chem – volume: 12 start-page: 703 year: 2013 end-page: 719 ident: b8-ijo-46-02-0474 article-title: Targeting the unfolded protein response in disease publication-title: Nat Rev Drug Discov – volume: 7 start-page: e40440 year: 2012 ident: b22-ijo-46-02-0474 article-title: The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome publication-title: PLoS One – volume: 94 start-page: 283 year: 2008 end-page: 286 ident: b18-ijo-46-02-0474 article-title: The aggresome pathway as a target for therapy in hematologic malignancies publication-title: Mol Genet Metab – volume: 359 start-page: 906 year: 2008 end-page: 917 ident: b2-ijo-46-02-0474 article-title: Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma publication-title: N Engl J Med – volume: 115 start-page: 727 year: 2003 end-page: 738 ident: b19-ijo-46-02-0474 article-title: The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress publication-title: Cell – volume: 37 start-page: 815 year: 2010 end-page: 820 ident: b36-ijo-46-02-0474 article-title: Clarithromycin attenuates autophagy in myeloma cells publication-title: Int J Oncol – volume: 29 start-page: 969 year: 2010 end-page: 980 ident: b21-ijo-46-02-0474 article-title: HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy publication-title: EMBO J – volume: 123 start-page: 1461 year: 2014 end-page: 1469 ident: b3-ijo-46-02-0474 article-title: A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma publication-title: Blood – volume: 13 start-page: 184 year: 2011 end-page: 190 ident: b9-ijo-46-02-0474 article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress publication-title: Nat Cell Biol – volume: 25 start-page: 3109 year: 2007 end-page: 3115 ident: b25-ijo-46-02-0474 article-title: Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma publication-title: J Clin Oncol – volume: 126 start-page: 793 year: 2013 end-page: 807 ident: b32-ijo-46-02-0474 article-title: Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration publication-title: Acta Neuropathol – volume: 42 start-page: 1541 year: 2013 ident: key20180107183959_b16-ijo-46-02-0474 article-title: Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells publication-title: Int J Oncol doi: 10.3892/ijo.2013.1870 – volume: 348 start-page: 2609 year: 2003 ident: key20180107183959_b1-ijo-46-02-0474 article-title: A phase 2 study of bortezomib in relapsed, refractory myeloma publication-title: N Engl J Med doi: 10.1056/NEJMoa030288 – volume: 146 start-page: 1239 year: 1999 ident: key20180107183959_b29-ijo-46-02-0474 article-title: Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera publication-title: J Cell Biol doi: 10.1083/jcb.146.6.1239 – volume: 29 start-page: 969 year: 2010 ident: key20180107183959_b21-ijo-46-02-0474 article-title: HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy publication-title: EMBO J doi: 10.1038/emboj.2009.405 – volume: 76 start-page: 397 year: 2011 ident: key20180107183959_b12-ijo-46-02-0474 article-title: Autophagy in protein and organelle turnover publication-title: Cold Spring Harb Symp Quant Biol doi: 10.1101/sqb.2011.76.011023 – volume: 38 start-page: 643 year: 2011 ident: key20180107183959_b15-ijo-46-02-0474 article-title: Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: Crosstalk among proteasome, autophagy-lysosome and ER stress publication-title: Int J Oncol – volume: 40 start-page: 1029 year: 2012 ident: key20180107183959_b17-ijo-46-02-0474 article-title: Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells publication-title: Int J Oncol doi: 10.3892/ijo.2011.1317 – volume: 287 start-page: 2317 year: 2012 ident: key20180107183959_b20-ijo-46-02-0474 article-title: Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini publication-title: J Biol Chem doi: 10.1074/jbc.M111.273730 – volume: 37 start-page: 815 year: 2010 ident: key20180107183959_b36-ijo-46-02-0474 article-title: Clarithromycin attenuates autophagy in myeloma cells publication-title: Int J Oncol – volume: 32 start-page: 2336 year: 2013 ident: key20180107183959_b39-ijo-46-02-0474 article-title: Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury publication-title: EMBO J doi: 10.1038/emboj.2013.171 – volume: 126 start-page: 793 year: 2013 ident: key20180107183959_b32-ijo-46-02-0474 article-title: Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration publication-title: Acta Neuropathol doi: 10.1007/s00401-013-1158-x – volume: 6 start-page: 1337 year: 2006 ident: key20180107183959_b33-ijo-46-02-0474 article-title: Ubiquitin proteasome system as a pharmacological target in neurodegeneration publication-title: Expert Rev Neurother doi: 10.1586/14737175.6.9.1337 – volume: 40 start-page: 634 year: 2013 ident: key20180107183959_b6-ijo-46-02-0474 article-title: Novel agents for multiple myeloma to overcome resistance in phase III clinical trials publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2013.07.007 – volume: 451 start-page: 1069 year: 2008 ident: key20180107183959_b11-ijo-46-02-0474 article-title: Autophagy fights disease through cellular self-digestion publication-title: Nature doi: 10.1038/nature06639 – volume: 13 start-page: 184 year: 2011 ident: key20180107183959_b9-ijo-46-02-0474 article-title: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress publication-title: Nat Cell Biol doi: 10.1038/ncb0311-184 – volume: 94 start-page: 283 year: 2008 ident: key20180107183959_b18-ijo-46-02-0474 article-title: The aggresome pathway as a target for therapy in hematologic malignancies publication-title: Mol Genet Metab doi: 10.1016/j.ymgme.2008.03.012 – volume: 12 start-page: 703 year: 2013 ident: key20180107183959_b8-ijo-46-02-0474 article-title: Targeting the unfolded protein response in disease publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3976 – volume: 100 start-page: 4389 year: 2003 ident: key20180107183959_b28-ijo-46-02-0474 article-title: Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0430973100 – volume: 51 start-page: 822 year: 2012 ident: key20180107183959_b7-ijo-46-02-0474 article-title: Targeting endoplasmic reticulum signaling pathways in cancer publication-title: Acta Oncol doi: 10.3109/0284186X.2012.689113 – volume: 120 start-page: 2817 year: 2012 ident: key20180107183959_b4-ijo-46-02-0474 article-title: A phase 2 study of single-agent carfilzomib (PX-171–003-A1) in patients with relapsed and refractory multiple myeloma publication-title: Blood doi: 10.1182/blood-2012-05-425934 – volume: 437 start-page: 41 year: 2013 ident: key20180107183959_b24-ijo-46-02-0474 article-title: Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.06.032 – volume: 359 start-page: 906 year: 2008 ident: key20180107183959_b2-ijo-46-02-0474 article-title: Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma publication-title: N Engl J Med doi: 10.1056/NEJMoa0801479 – volume: 34 start-page: 259 year: 2009 ident: key20180107183959_b13-ijo-46-02-0474 article-title: A role for ubiquitin in selective autophagy publication-title: Mol Cell doi: 10.1016/j.molcel.2009.04.026 – volume: 143 start-page: 1883 year: 1998 ident: key20180107183959_b30-ijo-46-02-0474 article-title: Aggresomes: a cellular response to misfolded proteins publication-title: J Cell Biol doi: 10.1083/jcb.143.7.1883 – volume: 121 start-page: 3554 year: 2011 ident: key20180107183959_b38-ijo-46-02-0474 article-title: Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection publication-title: J Clin Invest doi: 10.1172/JCI46095 – volume: 2010 start-page: 930509 year: 2010 ident: key20180107183959_b10-ijo-46-02-0474 article-title: Linking ER stress to autophagy: potential implications for cancer therapy publication-title: Int J Cell Biol doi: 10.1155/2010/930509 – volume: 7 start-page: e40440 year: 2012 ident: key20180107183959_b22-ijo-46-02-0474 article-title: The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome publication-title: PLoS One doi: 10.1371/journal.pone.0040440 – volume: 4 start-page: 2111 year: 2013 ident: key20180107183959_b31-ijo-46-02-0474 article-title: Spatiotemporally controlled induction of autophagy-mediated lysosome turnover publication-title: Nat Commun doi: 10.1038/ncomms3111 – volume: 123 start-page: 1461 year: 2014 ident: key20180107183959_b3-ijo-46-02-0474 article-title: A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma publication-title: Blood doi: 10.1182/blood-2013-07-517276 – volume: 67 start-page: 793 year: 2010 ident: key20180107183959_b26-ijo-46-02-0474 article-title: Vorinostat: a novel therapy for the treatment of cutaneous T-cell lymphoma publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp090247 – volume: 417 start-page: 455 year: 2002 ident: key20180107183959_b27-ijo-46-02-0474 article-title: HDAC6 is a microtubule-associated deacetylase publication-title: Nature doi: 10.1038/417455a – volume: 23 start-page: 33 year: 1998 ident: key20180107183959_b37-ijo-46-02-0474 article-title: Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells publication-title: Cell Struct Funct doi: 10.1247/csf.23.33 – volume: 14 start-page: 1129 year: 2013 ident: key20180107183959_b5-ijo-46-02-0474 article-title: Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70398-X – volume: 115 start-page: 727 year: 2003 ident: key20180107183959_b19-ijo-46-02-0474 article-title: The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress publication-title: Cell doi: 10.1016/S0092-8674(03)00939-5 – volume: 584 start-page: 1393 year: 2010 ident: key20180107183959_b14-ijo-46-02-0474 article-title: Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems publication-title: FEBS Lett doi: 10.1016/j.febslet.2009.12.047 – volume: 8 start-page: e76016 year: 2013 ident: key20180107183959_b23-ijo-46-02-0474 article-title: SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity publication-title: PLoS One doi: 10.1371/journal.pone.0076016 – volume: 25 start-page: 3109 year: 2007 ident: key20180107183959_b25-ijo-46-02-0474 article-title: Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma publication-title: J Clin Oncol doi: 10.1200/JCO.2006.10.2434 – volume: 112 start-page: 2917 year: 2008 ident: key20180107183959_b34-ijo-46-02-0474 article-title: Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA publication-title: Blood doi: 10.1182/blood-2007-12-130823 – volume: 34 start-page: 1336 year: 2014 ident: key20180107183959_b35-ijo-46-02-0474 article-title: Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport publication-title: Mol Cell Biol doi: 10.1128/MCB.00103-14 – reference: 23792097 - Biochem Biophys Res Commun. 2013 Jul 19;437(1):41-7 – reference: 17577020 - J Clin Oncol. 2007 Jul 20;25(21):3109-15 – reference: 19450525 - Mol Cell. 2009 May 15;34(3):259-69 – reference: 20145727 - Int J Cell Biol. 2010;2010:930509 – reference: 20075865 - EMBO J. 2010 Mar 3;29(5):969-80 – reference: 23989796 - Nat Rev Drug Discov. 2013 Sep;12(9):703-19 – reference: 24135408 - Semin Oncol. 2013 Oct;40(5):634-51 – reference: 24086678 - PLoS One. 2013;8(9):e76016 – reference: 22200786 - Int J Oncol. 2012 Apr;40(4):1029-39 – reference: 22792322 - PLoS One. 2012;7(7):e40440 – reference: 9864362 - J Cell Biol. 1998 Dec 28;143(7):1883-98 – reference: 23921551 - EMBO J. 2013 Aug 28;32(17):2336-47 – reference: 14675537 - Cell. 2003 Dec 12;115(6):727-38 – reference: 21364565 - Nat Cell Biol. 2011 Mar;13(3):184-90 – reference: 20811702 - Int J Oncol. 2010 Oct;37(4):815-20 – reference: 23546223 - Int J Oncol. 2013 May;42(5):1541-50 – reference: 22686473 - Acta Oncol. 2012 Sep;51(7):822-30 – reference: 18305538 - Nature. 2008 Feb 28;451(7182):1069-75 – reference: 20040365 - FEBS Lett. 2010 Apr 2;584(7):1393-8 – reference: 17009921 - Expert Rev Neurother. 2006 Sep;6(9):1337-47 – reference: 22069321 - J Biol Chem. 2012 Jan 20;287(4):2317-27 – reference: 21174067 - Int J Oncol. 2011 Mar;38(3):643-54 – reference: 12826635 - N Engl J Med. 2003 Jun 26;348(26):2609-17 – reference: 18641367 - Blood. 2008 Oct 1;112(7):2917-26 – reference: 9639028 - Cell Struct Funct. 1998 Feb;23(1):33-42 – reference: 21804191 - J Clin Invest. 2011 Sep;121(9):3554-63 – reference: 18472289 - Mol Genet Metab. 2008 Jul;94(3):283-6 – reference: 22833546 - Blood. 2012 Oct 4;120(14):2817-25 – reference: 24429336 - Blood. 2014 Mar 6;123(10):1461-9 – reference: 21813637 - Cold Spring Harb Symp Quant Biol. 2011;76:397-402 – reference: 23817530 - Nat Commun. 2013;4:2111 – reference: 12677000 - Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4389-94 – reference: 10491388 - J Cell Biol. 1999 Sep 20;146(6):1239-54 – reference: 12024216 - Nature. 2002 May 23;417(6887):455-8 – reference: 24469403 - Mol Cell Biol. 2014 Apr;34(7):1336-48 – reference: 24055414 - Lancet Oncol. 2013 Oct;14(11):1129-40 – reference: 18753647 - N Engl J Med. 2008 Aug 28;359(9):906-17 – reference: 23912309 - Acta Neuropathol. 2013 Dec;126(6):793-807 – reference: 20479100 - Am J Health Syst Pharm. 2010 May 15;67(10):793-7 |
SSID | ssj0025501 |
Score | 2.3191867 |
Snippet | The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits... |
SourceID | pubmedcentral proquest gale pubmed crossref spandidos |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 474 |
SubjectTerms | aggresome Animals Antibiotics Antineoplastic Combined Chemotherapy Protocols Apoptosis Apoptosis - drug effects Autophagy Autophagy (Cytology) Autophagy - drug effects Boronic Acids - administration & dosage Bortezomib Cell death Cell Line, Tumor Clarithromycin - administration & dosage Drug Synergism Drug therapy Endoplasmic reticulum Endoplasmic Reticulum - drug effects Endoplasmic Reticulum Stress - drug effects ER stress Health aspects Histone Deacetylase 6 Histone Deacetylases - drug effects Humans Hydroxamic Acids - administration & dosage Investigations Kinases Mice Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - genetics Multiple Myeloma - pathology Physiological aspects proteasome Proteasome Endopeptidase Complex - drug effects Proteins Pyrazines - administration & dosage |
Title | Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25422130 https://www.proquest.com/docview/1932824904 https://pubmed.ncbi.nlm.nih.gov/PMC4277245 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJgEviG8C2_ADgpeaJY4Tp09omzpNSK2maZP6Fjm2M4rWpJDuYX8J_y53Tpotk4bUl9bX2ul9_c6-OwN8DnVGbjvkUeli2q3SvFBK8USnodVZmpUlFSdPZ-nJhfwxT-bdhlvTpVVubKI31LY2tEe-T0Ajw1ghlN9XvzndGkWnq90VGo9hm1qXkVSr-W3AhejbB1wIYzh53rbHJrposb_4RZV_kfwmlIoHPum-Zb7jmu6nTT5Fpa_swtbNHZ90_AKed2CSHbTcfwmPXPUKnky74_LX8Pfc53mjd2KI81jfGsKyqs3-blhdMn1JMXe9dKyvZBwx379B06cjhrMzfU0dCPTlDVvhQIV2ATEqm5yxttiE-woU-mU6CWCWgCXOxzb5imx5467qpfbDzRu4OJ6cH53w7iYGbtIoWvNMGGEcMk4LUcZGhONYurEyKotM4ZLQqQJfGJDKJDS2KJJC6dCmRo-dw_gvjd_CVlVX7j2wDG2KSaxwcWQlWtvCjENnU4tICcGCVgGMNrzITdemnG7LuMoxXCHW5ci6nFiXE-sC-NKTr9r-HA8RfiLG5m15aa_X-QEFmBmGlVkAXz0FaTbOaHRXoIDrph5ZA8qdASVqpBkOb4Qn7yxCk9_KbwDvWjnqF4xBuhAIJgJQAwnrCagH-HCkWvz0vcAlPpuQSQCsl8X-W_j8XLYp5lLJD_9f1Ud4hv9V0iak78DW-s-120W8tS72vFLtwfbhZHZ6hu9mp9N_e94uWg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlEuiDeGQvfA4xK39nrtdQ4IVdAqpU0PKJVyM-vddUnV2ClOhfJL-Bf8Rmb8al0JbpVyyk7sdWZ25vu8M7MAbz0VU9j2XD-zAb2tUm4qpXRDFXlGxVGcZVScPD6ORifi6zScrsGfthaG0ipbn1g5alNoeke-Q0AjRq7giU-LC5dOjaLd1fYIjdosDu3qF1K28uPBF9TvO8739yafR25zqoCrI99fujHXXFuchOI8CzRHSi_sUGoZ-zq1oWdlih8kVyL0tEnTMJXKM5FWQ2uRy0QBXvcO3MXA6xHZk9MrgodovyJ4CJtcivR1T0-EBHxndkaVhr7Y5lIGvRh4MxJcC4U30zQ30MnkZmaK8loM3H8IDxrwynZra3sEazZ_DPfGzfb8E_g9qfLKMRoyxJWsa0VhWF5nm5esyJg6JY5fzC3rKicHrOoXoejbAcO7M3VJHQ_U6YotcCBHP4SYmO19Y3Vxi1tVvNCVaeeBGQKyeD_W5key-cqeF3NVDZdP4eRWdPQM1vMity-AxejDdGi4DXwj0LuneuhZExlEZghOlHRg0Ooi0U1bdDqd4zxBekSqS1B1CakuIdU58L4TX9T9QP4luEWKTepy1s6PJLtEaGOksbEDHyoJ8iR4R62aggicN_Xk6klu9iTRA-j-cGs8SeOByuRqvTjwvLajbsI8FJwjeHFA9iysE6Ce4_2RfPaj6j0u8Nm4CB1gnS12v8Lnd0Wd0i6kePn_WW3BxmgyPkqODo4PX8F9_N_COhl-E9aXPy_ta8R6y_RNtcAYfL_tFf0XSglphw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVCpcEG8Mhe6BxyUm9nrtdQ4IFZqopTSqqlbqzV3vrktQYweSCuWX8F_4dcz4RV0JbpVyyk7sdWZ25vu8M7MArzwVU9j2XD-zAb2tUm4qpXRDFXlGxVGcZVScfDCJdk_E59PwdA1-N7UwlFbZ-MTSUZtC0zvyAQGNGLmCJwZZnRZxuDP-MP_u0glStNPaHKdRmci-Xf1E-rZ4v7eDun7N-Xh0_GnXrU8YcHXk-0s35pprixNSnGeB5kjvhR1KLWNfpzb0rEzxg0RLhJ42aRqmUnkm0mpoLfKaKMDr3oJ1SayoB-sfR5PDo5buIfYv6R6CKJfiftXhEwECH0y_Ud2hL95xKYNORLweF64ExutJm7fR5eRmaorFlYg4vgd3ayjLtivbuw9rNn8AGwf1Zv1D-HVcZpljbGSIMlnbmMKwvMo9X7AiY-qcGH8xs6yto-yzsnuEom_7DO_O1CX1P1DnKzbHgRy9EiJkNjpiVamLW9a_0JVpH4IZgrV4P9ZkS7LZyl4UM1UOLx7ByY1o6TH08iK3T4HF6NF0aLgNfCPQ16d66FkTGcRpCFWUdKDf6CLRdZN0OqvjIkGyRKpLUHUJqS4h1TnwphWfV91B_iW4RYpNquLW1qsk20RvYyS1sQNvSwnyK3hHreryCJw3dejqSG52JNEf6O5wYzxJ7Y8Wyd_V48CTyo7aCfNQcI5QxgHZsbBWgDqQd0fy6deyE7nAZ-MidIC1ttj-Cp_fFVWCu5Di2f9ntQUbuJqTL3uT_edwB_-2sMqM34Te8selfYHAb5m-rFcYg7ObXtR_ACS6byI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+the+integrated+networks+of+aggresome+formation%2C+proteasome%2C+and+autophagy+potentiates+ER+stress-mediated+cell+death+in+multiple+myeloma+cells&rft.jtitle=International+journal+of+oncology&rft.au=MORIYA%2C+SHOTA&rft.au=KOMATSU%2C+SEIICHIRO&rft.au=YAMASAKI%2C+KAHO&rft.au=KAWAI%2C+YUSUKE&rft.date=2015-02-01&rft.pub=D.A.+Spandidos&rft.issn=1019-6439&rft.eissn=1791-2423&rft.volume=46&rft.issue=2&rft.spage=474&rft.epage=486&rft_id=info:doi/10.3892%2Fijo.2014.2773&rft_id=info%3Apmid%2F25422130&rft.externalDocID=PMC4277245 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1019-6439&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1019-6439&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1019-6439&client=summon |